pSvida to list on Nasdaq

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

WA-based biotech pSvida (ASX: PSD) is to reincorporate onto the Nasdaq, the American stock exchange.

The re-incorporation plan was first mooted in April. At a shareholders' meeting today, 94 per cent of shareholders, 192 in total, voted for the resolution, while six voted against it.

Between them the 192 shareholders hold around 96 per cent of the voting power.

The shareholders also voted to adopt a new employee incentive plan.

Related News

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd